Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
19 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07461818 | Point of Care - Triage and Treatment for Cervical Pre-cancer(POC) | recruiting | N/A | 5,000 | Basic Health International, Inc.OTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT03429582 | Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device | completed | N/A | 1,154 | The Cleveland ClinicOTHER | 2 | Aug 3, 2026 | clinicaltrials |
| NCT07482306 | Introducing a Telemedicine Strategy to Deliver Cervical Cancer Screening Results in El Salvador(Telemedine) | completed | N/A | 1,103 | The Cleveland ClinicOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07538050 | Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (Phase 2)(SCALE AIM 2) | recruiting | N/A | 1,000 | The Cleveland ClinicOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07508592 | Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal Surgery(SEGER-FIH) | completed | N/A | 10 | Seger Surgical SolutionsINDUSTRY | 1 | Jun 29, 2026 | clinicaltrials |
| NCT06815939 | Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer(OPTICS) | recruiting | N/A | 10,000 | DL AnalyticsINDUSTRY | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07246213 | CAYA Cancer Retrospective Cohort Study | recruiting | — | 18,000 | Resonance, Inc.OTHER | 4 | Dec 19, 2025 | clinicaltrials |
| NCT01358877 | A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer(APHINITY) | completed | Phase 3 | 4,804 | Hoffmann-La RocheINDUSTRY | 42 | Nov 28, 2025 | clinicaltrials |
| NCT07232355 | Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling(PROGRESS) | recruiting | — | 5,000 | Atila Biosystems Inc.INDUSTRY | 3 | Nov 19, 2025 | clinicaltrials |
| NCT03084081 | An Innovative Treatment for Cervical Precancer (UH3)(UH3) | completed | N/A | 1,132 | The Cleveland ClinicOTHER | 3 | Apr 6, 2025 | clinicaltrials |
| NCT02594371 | Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer | completed | Phase 3 | 402 | Athenex, Inc.INDUSTRY | 10 | Aug 3, 2022 | clinicaltrials |
| NCT03721562 | Antibiotic Resistance in Global Pediatric Oncology Centers | completed | — | 560 | St. Jude Children's Research HospitalOTHER | 4 | Aug 3, 2022 | clinicaltrials |
| NCT01566721 | A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer(SafeHER) | completed | Phase 3 | 2,577 | Hoffmann-La RocheINDUSTRY | 59 | Apr 27, 2021 | clinicaltrials |
| NCT01774786 | A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer(JACOB) | completed | Phase 3 | 780 | Hoffmann-La RocheINDUSTRY | 32 | Dec 30, 2020 | clinicaltrials |
| NCT02814448 | An Innovative Treatment for Cervical Pre Cancer(CryoPen) | completed | N/A | 130 | The Cleveland ClinicOTHER | 2 | Nov 20, 2018 | clinicaltrials |
| NCT02273973 | A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI) | completed | Phase 2 | 334 | Genentech, Inc.INDUSTRY | 22 | May 21, 2018 | clinicaltrials |
| NCT01724021 | A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a | completed | Phase 3 | 743 | Hoffmann-La RocheINDUSTRY | 32 | Jan 23, 2018 | clinicaltrials |
| NCT02151370 | An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian Cancer | completed | — | 3 | Hoffmann-La RocheINDUSTRY | 1 | May 30, 2014 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials